Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Economic Burden of Adults with Major Depressive Disorder in the United States (2019)
Paul E. Greenberg, A.S. Chitnis, Derek Louie, et al.
Advances in Therapy (2023) Vol. 40, Iss. 10, pp. 4460-4479
Open Access | Times Cited: 63

Showing 1-25 of 63 citing articles:

Management of Depression in Adults
Gregory E. Simon, Nathalie Moise, David C. Mohr
JAMA (2024) Vol. 332, Iss. 2, pp. 141-141
Closed Access | Times Cited: 26
Omics approaches open new horizons in major depressive disorder: from biomarkers to precision medicine
Fabiola Stolfi, Hugo Abreu, Riccardo Sinella, et al.
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 6
Strategies to Improve Women’s Mental Health Across the Life Course
Shannon D. Simonovich, Janna Stephens, Hsiang Huang, et al.
JOGN Nursing (2025) Vol. 54, Iss. 1, pp. 9-12
Closed Access
Antidepressants and Weight Gain: An Update on the Evidence and Clinical Implications
Lauren Moss, Marci Laudenslager, Kristine J. Steffen, et al.
Current Obesity Reports (2025) Vol. 14, Iss. 1
Closed Access
Insights for the Next Generation of Ketamine for the Treatment of Depressive Disorder
Allana Cristina Faustino Martins, Bretton Badenoch, Roberto da Silva Gomes
Journal of Medicinal Chemistry (2025)
Closed Access
Post-Master’s Psychiatric/Mental Health Nurse Practitioner Students’ Attitudes, Knowledge and Preferences for Providing Psychotherapy: A Qualitative Description Study
Joseph P. De Santis, Deborah Salani, Renessa Williams, et al.
Issues in Mental Health Nursing (2025), pp. 1-10
Closed Access
The Impact of Sinus Surgery for Chronic Rhinosinusitis on Concomitant Depression and Anxiety Symptoms: A Systematic Review and Meta‐analysis
Xing Yi Cheah, Chao Tan, Brian Sheng Yep Yeo, et al.
International Forum of Allergy & Rhinology (2025)
Open Access
Mental Health-Related Disability Days and Costs Among Patients with Treatment-Resistant Depression Initiated on Esketamine Nasal Spray and Conventional Therapies in the USA
Manish K. Jha, Maryia Zhdanava, Aditi Shah, et al.
Drugs - Real World Outcomes (2025)
Open Access
Feasibility and effectiveness of a smartwatch-based intervention program for ameliorating depressive symptoms: a pilot-study
Jeanette Tamm, Andy Brendler, Alexander Bauer, et al.
medRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
A real-world analysis of antidepressant medications in US veterans aged 60 years and older: a comparative analysis
Ryan D. Pittman, S. Scott Sutton, Joseph Magagnoli, et al.
Journal of Comparative Effectiveness Research (2025) Vol. 14, Iss. 2
Closed Access
Healthcare resource utilization and costs of using Cariprazine as the first versus subsequent adjunctive therapy for major depressive disorder
Prakash S. Masand, Anita H. Clayton, Mousam Parikh, et al.
Journal of Medical Economics (2025) Vol. 28, Iss. 1, pp. 235-244
Open Access
Electrodermal activity and skin temperature characteristics related to stress and depression: a 4-week observational study of office workers
Yuki Ishikawa, Tatsuki Sugio, Kiko Shiga, et al.
Journal of Affective Disorders Reports (2025), pp. 100877-100877
Open Access
Evaluating the efficacy of transcranial direct current stimulation (tDCS) in managing neuropathic pain-induced emotional consequences: Insights from animal models
Bahrie Ramadan, Vincent Van Waes
Neurophysiologie Clinique (2025) Vol. 55, Iss. 2, pp. 103055-103055
Open Access
A randomized controlled trial of a therapist-guided online intervention for depressed adults and its utility as an adjunctive to antidepressants and psychotherapy
Manuel Heinrich, Pavle Zagorscak, Christina Kampisiou, et al.
BMC Psychiatry (2025) Vol. 25, Iss. 1
Open Access
Healthcare resource utilization with adjunctive cariprazine and other atypical antipsychotics in patients with major depressive disorder
Anita H. Clayton, Mousam Parikh, Tracy Yee, et al.
Current Medical Research and Opinion (2025), pp. 1-24
Closed Access
The real-world impact of cariprazine on short- and long-term disability outcomes among commercially insured patients in the United States
Prakash S. Masand, Mousam Parikh, Jamie T. Ta, et al.
Journal of Medical Economics (2025), pp. 1-29
Open Access
Individual effects and interactions between ultrafine particles and extreme temperatures on hospital admissions of high burden diseases
Quan Qi, Yukang Xue, Najm Alsadat Madani, et al.
Environment International (2025) Vol. 197, pp. 109348-109348
Open Access
Longitudinal associations between white matter integrity, early life adversities, and treatment response following cognitive-behavioral therapy in depression
Kira Flinkenflügel, Tiana Borgers, Melissa Klug, et al.
Neuropsychopharmacology (2025)
Open Access
Ketogenic metabolic therapy in the remission of chronic major depressive disorder: a retrospective case study
Nicole Laurent, Erin L. Bellamy, Donika Hristova, et al.
Frontiers in Nutrition (2025) Vol. 12
Open Access
Discovery of Herbal Remedies and Key Components for Major Depressive Disorder Through Biased Random Walk Analysis on a Multiscale Network
Jun‐Ho Lee, Sungyoul Choi, Do-Eun Lee, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 2162-2162
Open Access
Why is rumination unhelpful in adolescents? Two studies examining the causal role of abstract processing
Eleanor Leigh, Lorna Taylor, Victoria Cole, et al.
Journal of Affective Disorders (2025) Vol. 379, pp. 213-222
Closed Access
Rethinking Depression—Beyond Neurotransmitters: An Integrated Psychoneuroendocrineimmunology Framework for Depression’s Pathophysiology and Tailored Treatment
Anna Giulia Bottaccioli, Mauro Bologna, Francesco Bottaccioli
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 6, pp. 2759-2759
Open Access
The efficacy of zuranolone in postpartum depression and major depressive disorder: a review & number needed to treat (NNT) analysis
S. Danielle, Nicholas Kleine, Kayla M. Teopiz, et al.
Expert Opinion on Pharmacotherapy (2024) Vol. 25, Iss. 1, pp. 5-14
Closed Access | Times Cited: 2
Exploring ketamine’s reinforcement, cue-induced reinstatement, and nucleus accumbens cFos activation in male and female long evans rats
Devin P. Hagarty, Adam Dawoud, Alfonso Brea Guerrero, et al.
Neuropharmacology (2024) Vol. 255, pp. 110008-110008
Closed Access | Times Cited: 2
Borneol and lactoferrin dual-modified crocetin-loaded nanoliposomes enhance neuroprotection in HT22 cells and brain targeting in mice
Zheren Tong, Xiao‐Lu Jie, Zi-Wei Chen, et al.
European Journal of Medicinal Chemistry (2024) Vol. 276, pp. 116674-116674
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top